Friday, April 14, 2017 12:00 PM EDT
It was a relatively slow week with key highlights including a complete response letter (CRL) for Merck’s label expansion efforts for its diabetes drugs and positive data on Roche’s lung cancer treatment.
|Zacks Research Pvt. Ltd.|
|March 2004 - Present (13 years 4 months)|
|Institute of Chartered Accountants of India|
|1998 / 2004|
|Loreto House, Calcutta|
|1986 / 1992|